Laurent Moll Sells 8,129 Shares of Arteris (NASDAQ:AIP) Stock

Key Points

• Laurent Moll, COO of Arteris, sold 8,129 shares of the company's stock at an average price of $8.74, resulting in a 2.06% decrease in his ownership position.
• Arteris, Inc. has a consensus analyst rating of "Buy" with a price target of $15.00, as several analysts have upgraded their ratings recently.
• Institutional investors own 64.36% of Arteris shares, with notable purchases made by firms such as Two Sigma Advisers LP and Cambridge Investment Research Advisors.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 8,129 shares of Arteris stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $8.74, for a total transaction of $71,047.46. Following the completion of the sale, the chief operating officer directly owned 386,552 shares of the company's stock, valued at approximately $3,378,464.48. This trade represents a 2.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Arteris Trading Up 1.5%

NASDAQ:AIP traded up $0.13 during trading hours on Tuesday, reaching $8.72. The company had a trading volume of 505,880 shares, compared to its average volume of 561,944. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.29. The firm's 50 day moving average price is $9.50 and its 200-day moving average price is $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). The business had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current year.

Analysts Set New Price Targets

AIP has been the topic of several research analyst reports. TD Cowen boosted their price target on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Rosenblatt Securities reiterated a "buy" rating and issued a $14.00 price target on shares of Arteris in a research note on Wednesday, May 21st. Finally, Wall Street Zen cut shares of Arteris from a "hold" rating to a "sell" rating in a research note on Sunday. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Arteris presently has a consensus rating of "Buy" and a consensus price target of $15.00.

Institutional Trading of Arteris

A number of large investors have recently made changes to their positions in the business. Cambridge Investment Research Advisors Inc. bought a new position in Arteris during the 1st quarter valued at about $95,000. Two Sigma Advisers LP grew its holdings in Arteris by 82.9% during the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock valued at $240,000 after purchasing an additional 10,700 shares during the last quarter. BNP Paribas Financial Markets bought a new position in Arteris during the 4th quarter valued at about $214,000. Price T Rowe Associates Inc. MD bought a new position in Arteris during the 4th quarter valued at about $117,000. Finally, Squarepoint Ops LLC bought a new position in Arteris during the 4th quarter valued at about $160,000. 64.36% of the stock is currently owned by institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.